Cantor Fitzgerald Lowers Trupanion (NASDAQ:TRUP) Price Target to $42.00

Trupanion (NASDAQ:TRUPGet Free Report) had its price target lowered by stock analysts at Cantor Fitzgerald from $50.00 to $42.00 in a note issued to investors on Wednesday, Marketbeat.com reports. The firm presently has a “neutral” rating on the financial services provider’s stock. Cantor Fitzgerald’s price objective indicates a potential upside of 23.86% from the company’s previous close.

A number of other analysts have also weighed in on TRUP. Wall Street Zen lowered shares of Trupanion from a “buy” rating to a “hold” rating in a report on Saturday, December 6th. Zacks Research upgraded shares of Trupanion from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 6th. Stifel Nicolaus reduced their price target on shares of Trupanion from $45.00 to $42.00 and set a “hold” rating for the company in a research report on Tuesday, November 18th. Piper Sandler lowered their price objective on Trupanion from $67.00 to $60.00 and set an “overweight” rating on the stock in a research report on Friday, December 19th. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of Trupanion in a research note on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Trupanion presently has an average rating of “Moderate Buy” and an average target price of $51.00.

Read Our Latest Report on TRUP

Trupanion Stock Performance

NASDAQ:TRUP opened at $33.91 on Wednesday. The business’s fifty day moving average is $36.77 and its 200 day moving average is $42.89. The firm has a market cap of $1.46 billion, a price-to-earnings ratio of 94.20 and a beta of 1.58. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.71 and a current ratio of 1.71. Trupanion has a 52-week low of $31.00 and a 52-week high of $57.88.

Trupanion (NASDAQ:TRUPGet Free Report) last posted its earnings results on Thursday, November 6th. The financial services provider reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.76). Trupanion had a net margin of 1.10% and a return on equity of 4.48%. The company had revenue of $366.92 million for the quarter, compared to analysts’ expectations of $361.58 million. During the same period in the previous year, the firm earned $0.03 EPS. The firm’s quarterly revenue was up 12.0% compared to the same quarter last year. Research analysts predict that Trupanion will post 0.13 EPS for the current year.

Insider Transactions at Trupanion

In other Trupanion news, COO John R. Gallagher sold 6,383 shares of the firm’s stock in a transaction dated Friday, November 28th. The stock was sold at an average price of $34.82, for a total transaction of $222,256.06. Following the sale, the chief operating officer owned 32,721 shares in the company, valued at $1,139,345.22. This trade represents a 16.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Margaret Tooth sold 9,605 shares of Trupanion stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $37.88, for a total value of $363,837.40. Following the sale, the chief executive officer directly owned 150,294 shares of the company’s stock, valued at approximately $5,693,136.72. This trade represents a 6.01% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 41,307 shares of company stock valued at $1,556,742. Insiders own 5.42% of the company’s stock.

Hedge Funds Weigh In On Trupanion

Large investors have recently modified their holdings of the company. Federated Hermes Inc. bought a new stake in Trupanion in the 3rd quarter worth approximately $33,000. Pilgrim Partners Asia Pte Ltd purchased a new position in shares of Trupanion during the third quarter worth approximately $39,000. Nisa Investment Advisors LLC lifted its holdings in shares of Trupanion by 44.1% in the 2nd quarter. Nisa Investment Advisors LLC now owns 980 shares of the financial services provider’s stock worth $54,000 after acquiring an additional 300 shares during the last quarter. Kelleher Financial Advisors purchased a new stake in shares of Trupanion in the 3rd quarter valued at $74,000. Finally, PNC Financial Services Group Inc. grew its holdings in shares of Trupanion by 21.7% during the 3rd quarter. PNC Financial Services Group Inc. now owns 2,678 shares of the financial services provider’s stock valued at $116,000 after purchasing an additional 478 shares during the last quarter.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.

Read More

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.